Madopar capsule (200/50) Australia - English - Department of Health (Therapeutic Goods Administration)

madopar capsule (200/50)

roche products pty ltd - levodopa, quantity: 200 mg; benserazide hydrochloride, quantity: 57 mg (equivalent: benserazide, qty 50 mg) - capsule, hard - excipient ingredients: iron oxide yellow; magnesium stearate; indigo carmine; povidone; gelatin; titanium dioxide; purified talc; microcrystalline cellulose; iron oxide red - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

NUFARM WEEDMASTER DST HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nufarm weedmaster dst herbicide

nufarm australia limited - glyphosate present as the potassium & mono-ammonium salt - soluble concentrate - glyphosate present as the potassium & mono-ammonium salt glycine active 470.0 g/l - herbicide - agricultural area - general | band spraying | barley - prior to sowing | berries & other small fruit | camellia or tea | chickpe - african lovegrass | african turnip weed | amaranth or amaranthus | amsinckia | annual ground cherry | annual phalaris | annual ryegrass | annual weeds | apple-of-peru | artichoke thistle | australian bindweed - seedling | ball mustard | bamboo | barbed wire grass | barley grass | barnyard grass or water grass | bathurst burr | bellvine - seedling | bent grass - agrostis capillaris | bent grass - agrostis spp. | bent grass - suppression | bitou bush or boneseed | black speargrass | blackberry | blackberry - rubus spp. | blackberry nightshade | bladder ketmia | blady grass | blue top - ageratum/heliotropium spp. | boggabri weed | boxthorn | bracken | brome grass | burr medic | button grass | californian burr | calomba daisy | caltrop - tribulis terrestis | caltrop or yellow vine | caltrop or yellow vine - seedling | camel or afghan melon | canary grass | capeweed | carpet grass | cat's ear or flatweed | charlock | chickweed | chinese scrub | cobbler's pegs | cocksfoot | columbus grass - seedling | common heliot

SET-UP BIAQUATIC 360 HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

set-up biaquatic 360 herbicide

imaspro resources sdn bhd - glyphosate present as the isopropylamine salt - suspension concentrate - glyphosate present as the isopropylamine salt glycine active 360.0 g/l - herbicide - agricultural area - general | agricultural/farm buildings | almond | aquatic weed control | avocado | banana | blueberry | build - african boxthorn | african lovegrass | alligator weed | amaranth or amaranthus | annual weeds - see label | artichoke thistle | bamboo | barley grass | barnyard or water grass | bathurst burr | bent grass - agrostis spp. | bitou bush or boneseed | blackberry | blady grass | bracken | brome grass | brown beetle grass - diplachne spp. | bullich | californian thistle | caltrop or yellow vine | camphor laurel | canary grass | capeweed | carpet grass | cat's ear or flatweed | chickweed | chinese scrub | cocksfoot | common reed or phragmites | couch | crofton weed | cumbungi | english couch or rope twitch | erodium spp. | eucalyptus | eucalyptus species - see label | flooded gum | fumitory | furze or gorse | ghost gum | glyceria or reed sweet grass | ground cherry - physalis angulata | groundsel bush | guinea grass | gum topped bloodwood | hawthorn | hedge or wild mustard | hoary cress or whiteweed | jarrah | johnson grass | kangaroo grass | kikuyu grass | lantana - lantana camara | lesser swinecress or bittercress

SHOOT 360 HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

shoot 360 herbicide

imaspro resources sdn bhd - glyphosate present as the isopropylamine salt - aqueous concentrate - glyphosate present as the isopropylamine salt glycine active 360.0 g/l - herbicide - agricultural area - general | almond | avocado | banana | blueberry | camellia or tea | chickpea | citrus | commercial/industria - african boxthorn | african lovegrass | amaranth or amaranthus | artichoke thistle | bamboo | barley grass | barnyard or water grass | bathurst burr | bent grass - agrostis spp. | bitou bush or boneseed | blackberry | blady grass | bracken | brome grass | brown beetle or silver top grass | bullich | californian thistle | caltrop or yellow vine | camphor laurel | canary grass | capeweed | carpet grass | cat's ear or flatweed | chickweed | chinese scrub | cobbler's pegs | cocksfoot | common reed or phragmites | couch grass | crofton weed | cumbungi | deadnettle | english couch or rope twitch | eucalyptus | flooded gum | fumitory | furze or gorse | general weed - see label | ghost gum | glyceria or reed sweet grass | ground or annual ground cherry | groundsel bush | guinea grass | gum topped bloodwood | hawthorn | hedge or wild mustard | hoary cress or whiteweed | jarrah | johnson grass | kangaroo grass | kikuyu grass | lantana - lantana camara | lesser swinecress or bittercress | liverseed or urochloa grass | lo

Norinyl-1 New Zealand - English - Medsafe (Medicines Safety Authority)

norinyl-1

pfizer new zealand limited - mestranol 0.05mg (overage of 3% added); norethisterone 1mg - tablet - 21 day - active: mestranol 0.05mg (overage of 3% added) norethisterone 1mg excipient: lactose monohydrate magnesium stearate maize starch povidone

Norinyl-1 New Zealand - English - Medsafe (Medicines Safety Authority)

norinyl-1

pfizer new zealand limited - mestranol 0.05mg (overage of 3% added); norethisterone 1mg - tablet - 28 day pack - active: mestranol 0.05mg (overage of 3% added) norethisterone 1mg excipient: lactose monohydrate magnesium stearate maize starch povidone lactose lactose monohydrate magnesium stearate microcrystalline cellulose sunset yellow fcf

Rifadin New Zealand - English - Medsafe (Medicines Safety Authority)

rifadin

pharmacy retailing (nz) ltd t/a healthcare logistics - rifampicin 150mg - capsule - 150 mg - active: rifampicin 150mg excipient: magnesium stearate maize starch - tuberculosis rifampicin is indicated in the treatment of all forms of tuberculosis, including fresh, advanced, chronic and drug resistant cases. rifampicin should be used in conjunction with at least one other antituberculosis medicine. leprosy rifampicin is indicated in the treatment of multibacillary and paucibacillary leprosy to effect a conversion of the infectious state to a non-infectious state. rifampicin should be used in conjunction with at least one other anti-leprosy drug. methicillin-resistant staphylococcal infections (mrsa) rifampicin can be used as an alternative to vancomycin in the treatment of mrsa. in such circumstances an appropriate companion antibiotic (e.g. fusidic acid) should always be employed. serious staphylococcal infections rifampicin has been used for the treatment of both life-threatening and serious staphylococcal infections. in such circumstances an appropriate companion antibiotic should be employed. brucellosis rifampicin may be used for the treatment of brucellosis. in such circumstances doxycycline should also be used. meningococcal carriers rifampicin is indicated for the treatment of asymptomatic carriers of n. meningitidis to eliminate meningococci from the nasopharynx. (rifampicin is not indicated for the treatment of meningococcal infection because of the possibility of the rapid emergence of resistant organisms). haemophilus influenzae rifampicin is indicated for the treatment of asymptomatic carriers of h influenzae and as chemoprophylaxis of exposed children of 4 years of age or younger. other infections infections caused by rifampicin-sensitive microorganisms such as staphylococci, streptococci, n gonorrhoeae, proteus sp., h. influenzae, e. coli and legionella sp. to prevent emergence of resistant organisms, rifampicin should be given with another antibacterial agent to which the organism has been shown to be susceptible.

Rifadin New Zealand - English - Medsafe (Medicines Safety Authority)

rifadin

pharmacy retailing (nz) ltd t/a healthcare logistics - rifampicin 300mg - capsule - 300 mg - active: rifampicin 300mg excipient: magnesium stearate maize starch - tuberculosis rifampicin is indicated in the treatment of all forms of tuberculosis, including fresh, advanced, chronic and drug resistant cases. rifampicin should be used in conjunction with at least one other antituberculosis medicine. leprosy rifampicin is indicated in the treatment of multibacillary and paucibacillary leprosy to effect a conversion of the infectious state to a non-infectious state. rifampicin should be used in conjunction with at least one other anti-leprosy drug. methicillin-resistant staphylococcal infections (mrsa) rifampicin can be used as an alternative to vancomycin in the treatment of mrsa. in such circumstances an appropriate companion antibiotic (e.g. fusidic acid) should always be employed. serious staphylococcal infections rifampicin has been used for the treatment of both life-threatening and serious staphylococcal infections. in such circumstances an appropriate companion antibiotic should be employed. brucellosis rifampicin may be used for the treatment of brucellosis. in such circumstances doxycycline should also be used. meningococcal carriers rifampicin is indicated for the treatment of asymptomatic carriers of n. meningitidis to eliminate meningococci from the nasopharynx. (rifampicin is not indicated for the treatment of meningococcal infection because of the possibility of the rapid emergence of resistant organisms). haemophilus influenzae rifampicin is indicated for the treatment of asymptomatic carriers of h influenzae and as chemoprophylaxis of exposed children of 4 years of age or younger. other infections infections caused by rifampicin-sensitive microorganisms such as staphylococci, streptococci, n gonorrhoeae, proteus sp., h. influenzae, e. coli and legionella sp. to prevent emergence of resistant organisms, rifampicin should be given with another antibacterial agent to which the organism has been shown to be susceptible.

Rifadin New Zealand - English - Medsafe (Medicines Safety Authority)

rifadin

pharmacy retailing (nz) ltd t/a healthcare logistics - rifampicin 20 mg/ml (5% overage is added.) - oral suspension - 100 mg/5ml - active: rifampicin 20 mg/ml (5% overage is added.) excipient: agar diolamine methyl hydroxybenzoate polysorbate 80 potassium sorbate propyl hydroxybenzoate purified water raspberry saccharin sodium metabisulfite sucrose - tuberculosis rifampicin is indicated in the treatment of all forms of tuberculosis, including fresh, advanced, chronic and drug resistant cases. rifampicin should be used in conjunction with at least one other antituberculosis medicine. leprosy rifampicin is indicated in the treatment of multibacillary and paucibacillary leprosy to effect a conversion of the infectious state to a non-infectious state. rifampicin should be used in conjunction with at least one other anti-leprosy drug. methicillin-resistant staphylococcal infections (mrsa) rifampicin can be used as an alternative to vancomycin in the treatment of mrsa. in such circumstances an appropriate companion antibiotic (e.g. fusidic acid) should always be employed. serious staphylococcal infections rifampicin has been used for the treatment of both life-threatening and serious staphylococcal infections. in such circumstances an appropriate companion antibiotic should be employed. brucellosis rifampicin may be used for the treatment of brucellosis. in such circumstances doxycycline should also be used. meningococcal carriers rifampicin is indicated for the treatment of asymptomatic carriers of n. meningitidis to eliminate meningococci from the nasopharynx. (rifampicin is not indicated for the treatment of meningococcal infection because of the possibility of the rapid emergence of resistant organisms). haemophilus influenzae rifampicin is indicated for the treatment of asymptomatic carriers of h influenzae and as chemoprophylaxis of exposed children of 4 years of age or younger. other infections infections caused by rifampicin-sensitive microorganisms such as staphylococci, streptococci, n gonorrhoeae, proteus sp., h. influenzae, e. coli and legionella sp. to prevent emergence of resistant organisms, rifampicin should be given with another antibacterial agent to which the organism has been shown to be susceptible.

Rifadin New Zealand - English - Medsafe (Medicines Safety Authority)

rifadin

sanofi-aventis new zealand limited - rifampicin 450mg - tablet - 450 mg - active: rifampicin 450mg